Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189390 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Shunchao Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Electronic address: yansc@cmu.edu.cn. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Hormonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 193 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is a heterogeneous disease with varying responses to hormonal therapies and immunotherapies. It is commonly characterized as a "cold" tumor; however, increasing evidence demonstrates the immunomodulatory effects of hormonal signals and an evolving tumor immune microenvironment following treatment. Several investigations have shown that anti-hormone treatment enhances the capacity of antitumor immune cells while reducing the population of immunosuppressive cells. Understanding the effects and mechanisms of hormone and anti-hormone therapies on the antitumor immune response is crucial for developing novel cancer treatment strategies. This review explores the complex interplay between hormonal signals and antitumor immune responses in breast cancer and outlines the research progress and potential applications of targeting hormone-related signals to reprogram the immune response against breast cancer. We also address the challenges, opportunities, and future directions in regulating hormonal signals to improve the efficacy of immunotherapy for individuals with breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Electronic address: yansc@cmu.edu.cn.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Zitieren
APA
Yan, S., Zhang, Z., Ji, J., Imam, M., & Wang, S. (2025). Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189390
Vancouver
Yan S, Zhang Z, Ji J, Imam M, Wang S. Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189390
BibTeX
@article{Yan2025,
author = {Yan, Shunchao and Zhang, Zhijie and Ji, Jiale and Imam, Murshid and Wang, Simiao},
title = {Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189390}
}
EUVIMED